Explainable Artificial Intelligence For The Detection and Characterisation of Stage B Heart Failure
Mirrored from arXiv — Machine Learning for archival readability. Support the source by reading on the original site.
Computer Science > Computers and Society
Title:Explainable Artificial Intelligence For The Detection and Characterisation of Stage B Heart Failure
Abstract:Stage B heart failure is characterized by asymptomatic structural or functional cardiac abnormalities. Identifying individuals at this stage is clinically important, as early detection may enable targeted interventions to prevent progression to symptomatic disease. Explainable artificial intelligence (XAI) may support early detection, transparent risk stratification, and selection of clinically actionable interventions. This review examines the use of XAI in detecting and characterizing stage B heart failure. A literature search of Web of Science, Scopus, and PubMed was conducted on 27 March 2026. Studies were included if they applied AI with XAI techniques to stage B heart failure. After screening, 20 studies were included. Data on modalities, outcomes, demographic reporting, and XAI methods were extracted and synthesized. SHAP was the most commonly used method, followed by LIME, saliency maps, and Grad-CAM; however, XAI adoption was inconsistent, with some studies relying on limited or ad hoc interpretability approaches. Notably, none compared explanations across sex or ethnic subgroups, despite evidence of subgroup differences in disease burden. Evaluation of XAI outputs was often insufficient: some studies did not assess explanations, while others relied only on literature-based comparisons, introducing potential bias. These limitations suggest explainability was not systematically validated or leveraged to support robust and fair clinical inference. XAI shows promise for improving transparency in stage B heart failure identification, but current implementations remain limited. Key gaps include limited consideration of sex and ethnicity, absence of subgroup-specific analyses, inconsistent evaluation, and lack of external validation, all of which constrain generalisability and clinical adoption.
| Subjects: | Computers and Society (cs.CY); Machine Learning (cs.LG) |
| Cite as: | arXiv:2606.30665 [cs.CY] |
| (or arXiv:2606.30665v1 [cs.CY] for this version) | |
| https://doi.org/10.48550/arXiv.2606.30665
arXiv-issued DOI via DataCite
|
Access Paper:
- View PDF
- HTML (experimental)
- TeX Source
References & Citations
Bibliographic and Citation Tools
Code, Data and Media Associated with this Article
Demos
Recommenders and Search Tools
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
More from arXiv — Machine Learning
-
Representation as a Bottleneck for Mechanistic Interpretability: The Manifestation Unit Protocol
Jul 2
-
SNAP-FM: Sparse Nonlinear Accelerated Projection for Physics-Constrained Generative Modeling
Jul 2
-
SemiScope: Disentangling Classifier Tuning and Joint Optimization in Semi-Supervised Security Classification
Jul 2
-
A Filtered Mixture-of-Generators for Fully Synthetic Survival Training
Jul 2
Discussion (0)
Sign in to join the discussion. Free account, 30 seconds — email code or GitHub.
Sign in →No comments yet. Sign in and be the first to say something.